BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Suloctidil

A peripheral vasodilator that was formerly used in the management of peripheral and cerebral vascular disorders. It is hepatotoxic and fatalities have occurred. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

138+ PubMed studies analyzed · 13 RCTs · Evidence Score: 48.2

Research Domains

Suloctidil has been studied across 18 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🦴 Bone & Joint, ⚡ Energy & Fatigue, 🧠 Focus & Attention. The primary research focus is 🔥 Metabolic with 15% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Suloctidil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Meropenem
2 shared targets
Levobupivacaine
2 shared targets
Chlormethiazole
2 shared targets
3-Iodobenzylguanidine
2 shared targets
Orotic
2 shared targets
Lactic
2 shared targets
Iodine
2 shared targets
Ethionamide
2 shared targets
Procarbazine
2 shared targets
Allantoin
2 shared targets
Loading evidence profile...

This evidence profile for Suloctidil is generated deterministically from 138 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.